Skip to content
Review Open access

Surgical intervention contribute to survival for patients with para-aortic lymph node metastasis from colorectal cancer, a meta-analysis and systematic review

Sep 2026 · Langenbeck's archives of surgery (Print) · 0 citations

TL;DR

A comprehensive meta-analysis of survival outcomes in CRC patients with PALNM undergoing PALND compared with non-surgical management provides the most comprehensive evidence to date that PALND is associated with a significant survival benefit in selected CRC patients with PALNM.

Abstract

Para-aortic lymph node metastasis (PALNM) in colorectal cancer (CRC) is a rare but prognostically significant condition, occurring in approximately 1–2% of patients. Current guidelines classify PALNM as stage IV disease but provide no clear consensus on optimal management. Treatment strategies vary widely, and the role of para-aortic lymph node dissection (PALND) remains controversial due to limited evidence from small, retrospective studies and the absence of randomized controlled trials. This study aimed to perform a comprehensive meta-analysis of survival outcomes in CRC patients with PALNM undergoing PALND compared with non-surgical management. A systematic literature search of PubMed, Embase, and Cochrane Library was conducted up to 23 March 2026. Eight retrospective cohort studies comprising 929 patients met the inclusion criteria. Individual patient data for overall survival (OS) were reconstructed from published Kaplan–Meier curves using validated methodology. Hazard ratios (HRs) with 95% confidence intervals (CIs) were pooled using random-effects models. Sensitivity, subgroup, and time-to-event analyses were performed, and risk of bias was assessed using the ROBINS-I V2 tool. Pooled analysis demonstrated that PALND was associated with significantly improved OS compared with non-surgical management (HR = 0.49, 95% CI: 0.39–0.63, P  < 0.001), representing a 51% reduction in mortality risk. Median OS was 36.8 months in the surgery group versus 12.9 months in the non-surgery group. The 3-year and 5-year OS rates were 50.5% and 38.8% in the surgery group, compared with 27.5% and 11.0% in the non-surgery group, respectively. Restricted mean survival time analysis demonstrated a 12.1-month gain (95% CI: 8.7–15.6, P  < 0.001) at 60 months. Sensitivity analyses confirmed the robustness of findings, with HRs ranging from 0.33 to 0.52 across multiple scenarios. Subgroup analyses revealed more pronounced benefit in metachronous metastases (HR = 0.34, 95% CI: 0.22–0.51) versus synchronous disease (HR = 0.63, 95% CI: 0.45–0.88). Moderate heterogeneity (I² = 43.1%) was observed overall but reduced to near-zero levels across all subgroup analyses. This IPD-based meta-analysis provides the most comprehensive evidence to date that PALND is associated with a significant survival benefit in selected CRC patients with PALNM. Despite the inherent limitations of retrospective data, these findings support consideration of surgical resection as a viable treatment option in appropriately selected patients.

Read PDF

Similar papers

Review Open access Oct 2026

Prognostic value of lymph node ratio in children with wilms tumor: a systematic review and meta-analysis

Higher LNR appears to be associated with poorer overall survival in children with WT and may serve as a useful prognostic indicator, while prospective studies are required to establish standardized clinical cut-offs and integrate LNR into formal risk-adapted protocols.

Jun-Yu Dong, J. Ni, Le-Le Li et al. · 0 citations
Review Sep 2026

Additional Surgery versus Surveillance After Non-curative ESD for Early Colorectal Cancer: A Systematic Review and Reconstructed Individual Patient Data Meta-analysis.

BACKGROUND AND AIMS Management after non-curative endoscopic submucosal dissection (ESD) for early colorectal cancer (CRC) remains controversial. We performed a pairwise and reconstructed individual patient data (IPD) meta-analysis to compare outcomes between surveillance and additional surgery. METHODS A systematic...

Mohammad Al Hayek, B. Sawaf, A. Capogreco et al. · 0 citations
Review Open access Oct 2026

Primary tumor resection versus systemic therapy alone in patients with colorectal cancer and unresectable distant metastases: a systematic review and meta-analysis

The role of primary tumor resection (PTR) in patients with colorectal cancer (CRC) and unresectable distant metastases remains controversial. While PTR may prevent tumor-related complications, it delays systemic therapy and carries surgical risks. This systematic review and meta-analysis synthesizes evidence from...

M. Kazi, A. S. A. Kaderi, K. Prakash · 0 citations
Open access Oct 2026

Laparoscopic para-aortic and pelvic lymphadenectomy before chemoradiotherapy was not associated with improved survival in patients with FIGO stage IIB–IIIC cervical cancer: a single-center retrospective study

Laroscopic para-aortic and pelvic lymphadenectomy before chemoradiotherapy was not associated with improved PFS or OS in this retrospective cohort, and Tumor histology, pelvic wall involvement, and imaging-positive lymph nodes were the main prognostic factors.

Qin Zhang, Lin Li, Xiu-Ying Li et al. · 0 citations
Open access Oct 2026

Impact of Neoadjuvant Chemotherapy on Pathological Outcomes and Survival in Muscle-Invasive Bladder Cancer: A Single-Center Retrospective Analysis

Neoadjuvant chemotherapy (NAC) is recommended for patients with muscle-invasive bladder cancer (MIBC); however, its impact on survival outcomes remains controversial in real-world clinical settings. This retrospective observational study evaluated the effect of NAC on pathological outcomes and overall survival among pa...

I. Topcu, Bulut Dural, Ömer Faruk Yıldırım et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.